GlassScriptPhysician profile
Abigail R Rauf
NPI 1902392517
$635.59
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.63 · 2023: $278 · 2024: $148 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $107.63 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $107.58 | 2022-2023 | |
| Hologic Sales and Service, LLC | $100.48 | 2022-2025 | Aptima, Omni Hysteroscope, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $81.79 | 2022-2025 | |
| Exeltis, USA INC. | $73.25 | 2023-2025 | Slynd |
| Pfizer INC. | $43.47 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $35.75 | 2024 | Gardasil, Gardasil 9 |
| Mayne Pharma Commercial LLC | $33.22 | 2023 | |
| Biogen, INC. | $22.20 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $17.30 | 2022 | |
| Sumitomo Pharma America, INC. | $12.92 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Rauf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.